These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8603381)

  • 1. MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors.
    Kavallaris M; Leary JA; Barrett JA; Friedlander ML
    Cancer Lett; 1996 Apr; 102(1-2):7-16. PubMed ID: 8603381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
    Oda Y; Röse I; Radig K; Wagemann W; Mittler U; Roessner A
    Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
    Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
    Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
    Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.
    Ota E; Abe Y; Oshika Y; Ozeki Y; Iwasaki M; Inoue H; Yamazaki H; Ueyama Y; Takagi K; Ogata T
    Br J Cancer; 1995 Sep; 72(3):550-4. PubMed ID: 7669560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance-associated protein (MRP) in haematological malignancies.
    Nooter K; Burger H; Stoter G
    Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.
    Fillpits M; Suchomel RW; Dekan G; Stiglbauer W; Haider K; Depisch D; Pirker R
    Br J Cancer; 1997; 75(2):208-12. PubMed ID: 9010028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
    Ogretmen B; Barredo JC; Safa AR
    J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines.
    Ogretmen B; Bahadori HR; McCauley MD; Boylan A; Green MR; Safa AR
    Int J Cancer; 1998 Mar; 75(5):757-61. PubMed ID: 9495245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
    Gao Z; Gao Z; Fields JZ; Boman BM
    Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.